MedTrace Logo

Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

NCT03194061 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-01-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the feasibility of hypofractionated radiation therapy and concomitant chemotherapy with cisplatin for locally advanced head and neck cancer in a high volume brazilian center.

Conditions

  • Radiotherapy; Complications

Interventions

RADIATION

Hypofractionated Radiotherapy

20 fractions of 275cGy 5 days/week

DRUG

Weekly cisplatin

Concomitant weekly cisplatin 35mg/m2 x 4 weeks

Sponsors & Collaborators

  • Barretos Cancer Hospital

    lead OTHER

Principal Investigators

  • Alexandre A Jacinto, MD · Barretos Cancer Hospital

  • Andre Lopes Carvalho, Phd · Barretos Cancer Hospital

  • Luciano Souza Viana, Phd · Barretos Cancer Hospital

  • Pedro de Marchi · Barretos Cancer Hospital

  • Eronides Salustiano Batalha · Barretos Cancer Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-08-31
Completion
2019-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03194061 on ClinicalTrials.gov